Background/Purpose: Vascular anomalies are diagnosed prenatally with increasing frequency. The authors reviewed a group of children treated at their center who had an abnormal prenatal diagnosis to determine (1) fetal age at which the vascular anomaly was detected, (2) general diagnostic accuracy, and (3) impact on ante-and postnatal care. Their findings are compared with reported cases and series. The authors clarify appropriate terminology and underscore the need for interdisciplinary participation of specialists in the field of vascular anomalies.
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V
ASCULAR ANOMALIES are encompassed in 2 major categories: (1) vascular tumors, which are proliferative endothelial lesions, such as hemangiomas, and (2) vascular malformations, which are developmental aberrations of hematic or lymphatic vessels. 1 At our vascular anomalies center, we have received several referrals for affected fetuses. In addition, a number of our patients were documented to have prenatal pathology, some of whom had an inaccurate prenatal diagnosis. There now are numerous case reports of vascular anomalies detected in utero (Table 1) . However, case reports published to date have been sporadic, often including small numbers of patients. In addition, there is a tendency for incorrectly diagnosed cases to go unpublished. This study was designed to determine the accuracy of prenatal ultrasonography in detecting vascular anomalies. Specificity and sensitivity of this modality for diagnosing vascular anomalies could not be assessed because we focused on a group of patients with these disorders rather than on a mixed population of children with and without disease.
MATERIALS AND METHODS
Patients presenting to our vascular anomalies center during a 1-year period (September 1999 through August 2000) who were referred prenatally or whose parents reported a prenatally diagnosed abnormality were included in this study. This study was approved by the Committee on Clinical Investigation of Children's Hospital, Boston. Specific information obtained included prenatal and postnatal diagnosis, fetal age at diagnosis, associated anomalies (such as polyhydramnios or fetal hydrops), mode of delivery (vaginal, cesarean, or cesarean with exit), and morbidity or mortality during the first month of life. These data were collected from interviews with parents, review of preand postnatal charts, and discussions with the involved obstetrician.
There were multiple obstetricians and radiologists with varying levels of expertise involved in prenatal diagnosis. Postnatal diagnoses were assigned by our team of vascular anomaly physicians who reached a consensus after patient examination (where possible) or review of medical history, clinical photographs, radiographic studies, and laboratory studies. Our aim was to compare diagnoses during fetal life with those postnatally. The specific criteria that each ultrasonographer used to establish each prenatal diagnosis is outside the scope of this report. NOTE. This literature review does not include patients reported to have "eponymous" vascular anomalies where correct classification of the disorder could not be ascertained. For example, the incorrect term "Klippel-Trenaunay-Weber" precludes determination of whether a patient has Klippel-Trenaunay syndrome (CLVM) or Parkes Weber syndrome (CAVM). Nor did we include case series in which a diagnosis of posterior nuchal translucency could not be distinguished clearly from LM. We also excluded reported cases of "cavernous hemangioma" because this term does not differentiate between true hemangioma and venous malformation; it has been applied to both.
Abbreviations: CS, cesarean section; VD, vaginal delivery; NA, not available; Dx, diagnosis.
RESULTS
The results are summarized in Tables 2, 3 Seventeen patients (59%) had a correct diagnosis, whereas 12 (41%) had an incorrect diagnosis. In the correct diagnosis group, there were 5 hemangiomas, 10 LMs and 2 CLVMs. Cesarean was the most common mode of delivery (11 cases, 64%); 2 of these were ex utero intrapartum (EXIT) procedures, both done for LMs threatening the airway. One patient required intubation with deferred tracheostomy, and another required immediate tracheostomy. Vaginal delivery accounted for 35% (6 cases). There were no deaths nor neonatal morbidity in this group. The incorrect diagnosis group (n ϭ 12) included 2 hemangiomas, 6 LMs, 1 CLVM, 1 AVM, and 1 BRBNS. There was 1 neonatal death-an infant with fetal congestive heart failure and hydrops diagnosed prenatally. Embolization failed to control the high flow through a massive AVM of the pelvis and lower extremity, which became obvious when the infant was delivered.
There was notable morbidity in the incorrect diagnosis hemangioma subgroup. One infant with a hepatic hemangioma diagnosed antenatally was found, on postnatal imaging and biopsy, to have neuroblastoma. A second infant, a boy with a perineal, pelvic, and extremity hemangioma, received an incorrect gender assignment, presumably secondary to scrotal swelling mimicking the appearance of female labia. Although his right lower extremity was detected to be larger prenatally, there was no documentation of increased blood flow through a massive hemangioma with arteriovenous fistulous components. Although there was no evidence of cardiac failure in utero, this infant became critically ill with high output cardiac failure, resulting in a long distance emergent transfer to our institution. Postnatally, this infant required 20 resections for nonviable extremity and perineal tissue (finally resulting in a high thigh amputation) and a number of embolizations to control congestive heart failure. A third infant was felt to have a cardiac teratoma that was found to be a right atrial hemangioma on surgical exploration at 3 days of life.
Additional morbidity was seen among incorrectly diagnosed LMs. One patient referred to our center postnatally with an LM of the hand had a prenatal diagnosis of "amniotic band syndrome." Fetal surgery was performed with laser release of the suspected amniotic band over the volar wrist. This was followed by premature delivery of the infant. When the infant was several months old, a dorsal debulking of the malformation was done at our institution. Postoperatively, there was profound venous engorgement of the hand that required application of leeches. This complication was ascribed to impaired venous drainage of the volar hand because of deep scar secondary to fetal intervention (Fig 1) . A second infant with LM was diagnosed as having intrauterine bowel perforation; surgical exploration on the first day of life revealed intraabdominal LM.
In the incorrect diagnosis group, vaginal deliveries were most common (8 cases, 67%); cesarean sections were done in the remaining cases (4 cases, 33%) with no EXIT procedures.
DISCUSSION
On the basis of cellular kinetics and clinical behavior, there are 2 major categories of vascular anomaliestumors and malformations. 1, 2 The most common vascular tumor is hemangioma of infancy. Approximately 30% of hemangiomas are nascent at birth, presenting as a premonitory cutaneous mark, whereas two thirds of hemangiomas appear postnatally (typically around 2 weeks of age). 1 There is an uncommon variant termed congenital hemangioma that evolves during fetal life and manifests fully developed at birth. This subset has the greatest potential to be detected prenatally. Congenital hemangiomas are subdivided further according to their postnatal behavior. Most lesions involute more rapidly than common postnatal infantile hemangiomas ("rapidlyinvoluting congenital hemangiomas"), 3 do not regress and persist into late childhood ("noninvoluting congenital hemangiomas"). 4 In our series, 4 of 7 hemangiomas were diagnosed correctly by sonography. Two of these were congenital hemangioma of the scalp, discovered early during the second trimester. Although they showed signs of regression during the first few weeks of life, they were excised in infancy. Bleeding and ulceration at a site at which the anticipated scar from ulceration will be more pronounced than that from excision is one of few indications for early resection of a hemangioma. Scalp hemangioma has a tendency to ulcerate, causing alopecia. Moreover, the scalp of an infant is lax, facilitating closure and excision, as compared with later childhood.
whereas others
Hemangiomas generally pose few problems in terms of delivery or neonatal well being. We have, however, seen hepatic hemangiomas with congestive heart failure as a consequence of arteriovenous shunting or result in hypoventilation from increased intraabdominal pressure. 5 The remaining 2 correctly diagnosed hemangiomas were hepatic (1 with additional intracranial lesions). In one of these, accurate prenatal diagnosis in the fetus with evolving cardiac decompensation prompted administration of corticosteroids to the mother during the antenatal period with a successful outcome. 6 In the other, cesarean delivery was done with a neonatology team prepared to receive the infant. In both cases, accurate diagnosis contributed to optimized antenatal care.
We also have seen neonates with congestive heart failure as a result of hemangiomas with arteriovenous shunting in extrahepatic locations, although this is very rare. This is illustrated in the infant with the perineal and lower extremity hemangioma (erroneously ascribed a prenatal female gender) who had high-output cardiac decompensation during the first month of life. Multiple arteriovenous fistulae were noted on angiographic study.
The 2 other infants with incorrectly diagnosed hemangioma (the atrial hemangioma diagnosed prenatally to be a teratoma and the hepatic neuroblastoma antenally thought to be hemangioma) underscore the importance of differential diagnosis. Accurate prenatal diagnosis in these patients might have optimized the antenatal course. Congenital fibrosarcoma also has been confused with hemangioma in the neonatal period. 7 Vascular malformations are designated according to the predominant channel type as capillary malformation (CM), lymphatic malformation (LM), venous malformation (VM), arteriovenous malformation (AVM), and capillary-lymphatico-venous malformation (CLVM). 1 Malformations with an arterial component are rheologically fast-flow, whereas capillary, lymphatic, and venous anomalies are slow-flow in nature.
The most commonly diagnosed malformation in our series was LM, followed by CLVM. LM consists of localized or diffuse aberrantly formed lymphatic channels and cysts. The terms cystic hygroma and lymphangioma are outdated and contribute to diagnostic confusion. Sites of predilection for LM include, in order of prevalence, the cervicofacial region, axilla, mediastinum, and extremities. It is useful to designate LMs as predominantly microcystic or macrocystic on radiographic or histologic evaluation. Most LMs are obvious at birth, but they also manifest during the first 2 years of life or, occasionally, in later childhood.
Sonographic examination of an LM generally shows a cystic, anechoic mass that may be unicameral or multilocated with multiple thin septae. 8 Hemorrhagic areas within LM may be detected as hyperechoic foci within the mass. The differential diagnosis of a fetal multilocular cystic mass in the abdomen includes a congenital fibrosarcoma, cystic teratoma, 9 enteric duplication cyst, mesenteric cyst, hepatic mesenchymal hamartoma, multilocular cystic nephroma, choledochal cyst, and urachal cysts.
The differential diagnosis of a cervical cystic mass includes cystic teratoma, thymic cyst, and a congenital fibrosarcoma. 10 A clear distinction should be made between posterior nuchal translucency (PNT) seen during the first and early second trimester, and cervicofacial LM diagnosed during the second and third trimesters. The term cystic hygroma has caused diagnostic confusion in this regard. PNT has been referred to as fetal cystic hygroma, a term also applied to fetal LM. 11 PNT is associated with increased risk of aneuploidy, determined to be 62% in a review of 740 karyotyped cases. 11, 12 In the presence of a normal karyotype, a fetus with a first trimester nuchal translucency has an equivocal prognosis with a normal outcome expected in 80% of pregnancies carried to the third trimester. Dysmorphic features are noted in 20% of liveborn infants, but do not include LM. 13 Normal outcome is highest when the fetal translucency resolves spontaneously, typically before 20 weeks gestation. 11 In contrast, an LM typically is noted at a later gestational age. In our series, the correct diagnosis was ascertained generally between 24 and 37 weeks (with the exception of 3 patients diagnosed at 16, 17, and 20 weeks). Cervical LM generally is anterior or lateral, and may be unilateral or bilateral, in comparison with nuchal cysts, which are invariably bilateral, symmetric, and posterior. 11 Accurate prenatal diagnosis of an LM permits precise planning for delivery and postnatal care. The two EXIT procedures in this series, done for fetuses with large anterior cervical malformation, permitted assessment of airway patency before clamping the umbilical cord. If laryngeal LM precludes intubation, tracheostomy can be performed under controlled circumstances. In one case, intubation was possible; in the other, tracheostomy was required. Asphyxia and death have been reported in a neonate with a prenatally diagnosed cervical LM in which an EXIT procedure was not done. 14 In other cases in our series, cesarean section without an EXIT procedure was planned to avoid intrapartum complications. Lymphatic malformation has been reported as a cause of shoulder dystocia. 15 Incorrect prenatal diagnosis of LM was associated with morbidity in this series, illustrated by unnecessary fetal surgery for the LM of the hand that was diagnosed to be "amniotic band syndrome" on prenatal sonography. It is conceivable that both LM and amniotic band syndrome were present in this patient. However, such an association has not been observed at our vascular anomalies center, nor reported in the literature.
Hydrops fetalis in association with a vascular anomaly is a poor prognostic indicator, as it is with fetal tumors. 16 In the published case reports summarized in Table 1 , 3 of the 5 hydropic fetuses died; the other 2 were delivered early and survived after complicated neonatal intensive care unit courses. In our series, hydrops was seen in 1 fetus. In spite of an emergent cesarean delivery, the neonatal course was complicated by high output cardiac failure and death.
There were 2 antepartum referrals (during the reviewed interval) to our center for hydrops with fetal ascites and pleural effusion where generalized malformation of the thoracic duct or cisterna chyli was suspected. These were not included in this series because anatomic demonstration of lymphatic abnormalities was not possible. One of these infants died on day 1 of life with massive chylous ascites and chylous pleural effusions. The second infant died at the age of 1 year with recalcitrant chylous ascites and chylous pleural effusions after thoracic duct ligation, pleurodesis, and a complicated course in the intensive care unit (other anomalies also were present in this infant).
Accurate prenatal diagnosis of a vascular anomaly permits fetal intervention, as exemplified by a fetus in this series whose cardiac decompensation was corrected after administration of maternal corticosteroids. 6 There is a reported case of a fetal LM treated with intralesional injection of OK-432. 17 It is not always clear in these cases whether fetal intervention altered the natural history of the disorder. In the case of sclerotherapy, for example, 2 posterior cysts were injected that could have been spontaneously resolving nuchal translucencies rather than a true LM. However, these examples highlight the principle of in utero therapy for vascular anomalies that threaten the life of the fetus. This series illustrates a number of emerging concepts. Vascular anomalies can be diagnosed prenatally, typically during the second and third trimesters of pregnancy. Unfortunately, these anomalies frequently are misdiagnosed. Pediatric surgeons consulted regarding a fetal tumor should include vascular anomaly on their differential diagnostic list. Proper diagnosis facilitates optimal planning for delivery and neonatal care. Incorrect diagnosis may result in fetal morbidity and illadvised treatment. A window for fetal intervention, including pharmacologic therapy, may open during later gestation.
Discussion
T.M. Crombleholme (Philadelphia, PA): Very nice presentation. The fetus that you mentioned actually did have amniotic band syndrome, and the band was lysed in utero, and the lymphatic malformation that you see actually is a secondary process. We have seen this in the fetal lamb model of amniotic band syndrome. What you saw postnatally is very consistent with an amniotic band obstruction that is treated in utero.
S. Fishman (response):
I appreciate that comment. I was not attempting to point fingers. We certainly considered that possibility, and I would agree that is possible. Most cases of amniotic band syndromes have atrophy distal to the band, but it certainly seems teleologically possible that constriction of an extremity could lead to lymphatic maldevelopment or hyperplasia. Histologically and radiographically, this was typical lymphatic malformation.
